Article
Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency in Zhejiang province, China.
Clinica chimica acta; international journal of clinical chemistry - 1 Mar 2023
Cheng Yi, Chen Peichun, Yu Zinan, Yin Xiaoshan, Zhang Chao, Miao Haixia, Huang Xinwen
Abstract excerpt
BACKGROUND: 3-Methylcrotonyl-CoA carboxylase deficiency (3-MCCD) is an autosomal recessive inborn defect of leucine catabolism caused by MCCC1 or MCCC2 variants. 3-MCCD is considered to be a relatively benign disorder with favorable outcome. We report the biochemical, clinical, and molecular features of patients with 3-MCCD. METHODS: From January 2009 to August 2022, 4,402,587 newborns were screened by tandem...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
